Comment
doi: 10.1001/jamaoto.2020.4275.
Regarding Use of Topical Steroids in Patients With COVID-19-Associated Olfactory Loss
Affiliations
- PMID: 33211102
- DOI: 10.1001/jamaoto.2020.4275
Item in Clipboard
Comment
Regarding Use of Topical Steroids in Patients With COVID-19-Associated Olfactory Loss
JAMA Otolaryngol Head Neck Surg.
.
No abstract available
Comment in
-
Regarding Use of Topical Steroids in Patients With COVID-19-Associated Olfactory Loss-Reply.JAMA Otolaryngol Head Neck Surg. 2021 Jan 1;147(1):110-111. doi: 10.1001/jamaoto.2020.4276. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 33211079 Free PMC article. No abstract available.
Comment on
-
Treatment Recommendations for Persistent Smell and Taste Dysfunction Following COVID-19-The Coming Deluge.JAMA Otolaryngol Head Neck Surg. 2020 Aug 1;146(8):733. doi: 10.1001/jamaoto.2020.1378. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 32614399 Free PMC article. No abstract available.
Similar articles
-
Treatment Recommendations for Persistent Smell and Taste Dysfunction Following COVID-19-The Coming Deluge.JAMA Otolaryngol Head Neck Surg. 2020 Aug 1;146(8):733. doi: 10.1001/jamaoto.2020.1378. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 32614399 Free PMC article. No abstract available.
-
Regarding Use of Topical Steroids in Patients With COVID-19-Associated Olfactory Loss-Reply.JAMA Otolaryngol Head Neck Surg. 2021 Jan 1;147(1):110-111. doi: 10.1001/jamaoto.2020.4276. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 33211079 Free PMC article. No abstract available.
-
Systemic steroids may enhance recovery from loss of smell and taste in hospitalized coronavirus disease 2019 (COVID-19) patients: an observational study.Int Forum Allergy Rhinol. 2021 Dec;11(12):1689-1693. doi: 10.1002/alr.22848. Epub 2021 Jun 16. Int Forum Allergy Rhinol. 2021. PMID: 34132052 Free PMC article. No abstract available.
-
[Taste and smell loss in patients with COVID-19].Ugeskr Laeger. 2020 Aug 31;182(36):V06200442. Ugeskr Laeger. 2020. PMID: 33000727 Review. Danish.
-
Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options.Asian Pac J Allergy Immunol. 2020 Jun;38(2):69-77. doi: 10.12932/AP-030520-0826. Asian Pac J Allergy Immunol. 2020. PMID: 32563234 Review.
Cited by
-
Corticosteroids for COVID-19-induced olfactory dysfunction: A comprehensive systematic review and meta-analysis of randomized controlled trials.PLoS One. 2023 Dec 21;18(12):e0289172. doi: 10.1371/journal.pone.0289172. eCollection 2023. PLoS One. 2023. PMID: 38127940 Free PMC article.
-
Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.Cochrane Database Syst Rev. 2021 Jul 22;7(7):CD013877. doi: 10.1002/14651858.CD013877.pub2. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 Sep 5;9:CD013877. doi: 10.1002/14651858.CD013877.pub3. PMID: 34291812 Free PMC article. Updated.
-
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.Cochrane Database Syst Rev. 2021 Jul 22;7(7):CD013876. doi: 10.1002/14651858.CD013876.pub2. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 Sep 5;9:CD013876. doi: 10.1002/14651858.CD013876.pub3. PMID: 34291813 Free PMC article. Updated.
-
Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.Cochrane Database Syst Rev. 2022 Sep 5;9(9):CD013876. doi: 10.1002/14651858.CD013876.pub3. Cochrane Database Syst Rev. 2022. PMID: 36062970 Free PMC article.
-
Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.Cochrane Database Syst Rev. 2022 Sep 5;9(9):CD013877. doi: 10.1002/14651858.CD013877.pub3. Cochrane Database Syst Rev. 2022. PMID: 36063364 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
